Phase 3b Findings on Guselkumab Indicate Rapid Scalp Psoriasis Clearance in Patients of Color

These data were announced by Johnson & Johnson this week and show several encouraging findings regarding guselkumab’s use among patients of different skin types.

Related Keywords

Hawaii ,United States ,Guselkumab Tremfya ,Andrew Alexis , ,Weill Cornell Medicine ,Maui Derm Hawaii ,Guselkumab Significant ,Rapid Scalp Clearance Data ,Scalp Specific Investigator Global Assessment ,Psoriasis Scalp Severity Index ,Scalp Surface Area ,Scalp Itch Numeric Rating Scale ,Psoriasis Symptoms ,Signs Diary ,Dermatology Life Quality Index ,Guselkumab ,Scalp ,Psoriasis ,People Of Color ,Tremfya ,